ING Groep N.V. (LON:0RIC)

Market Cap	48.52B
Revenue (ttm)	16.80B
Net Income (ttm)	4.11B
Shares Out	n/a
EPS (ttm)	1.32
PE Ratio	11.81
Forward PE	9.11
Dividend	1.04 (5.08%)
Ex-Dividend Date	Apr 24, 2025

Volume	735,491
Average Volume	2,089,382
Open	20.45
Previous Close	20.50
Day's Range	19.57 - 20.80
52-Week Range	14.24 - 20.80
Beta	1.28
RSI	73.23
Earnings Date	Jul 31, 2025

About Verve Therapeutics

ING Groep N.V. provides various banking products and services in the Netherlands, Belgium, Germany, rest of Europe, and internationally. The company operates through five segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, and Wholesale Banking. It accepts current and savings accounts, as well as time deposits. The company also offers business lending products; SME loans; consumer lending products, such as residential mortgage loans and other consumer lending loans; and mortgages. In addition, it provides working capital...

• Industry: Commercial Banks
• Founded: 1762
• Employees: 60,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RIC

Financial Performance

In 2024, ING Groep's revenue was 20.05 billion, an increase of 13.77% compared to the previous year's 17.63 billion. Earnings were 5.33 billion, an increase of 28.84%.